{"title":"New approach to mental health: interview with Jeff Hoeltzel, Community Living Room. Interview by John S. James.","authors":"Jeff Hoeltzel","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A Philadelphia program for people with a mental health diagnosis who are HIV-positive has won national recognition. We interviewed its founder for ideas and approaches others can use.</p>","PeriodicalId":80392,"journal":{"name":"AIDS treatment news","volume":" 421","pages":"2-5"},"PeriodicalIF":0.0,"publicationDate":"2006-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26641545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Fuzeon: avoiding injection-site reactions.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The FDA changed the FUZEON prescribing information to help avoid this common and unpleasant side effect of the drug.</p>","PeriodicalId":80392,"journal":{"name":"AIDS treatment news","volume":" 421","pages":"5"},"PeriodicalIF":0.0,"publicationDate":"2006-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26641548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Sustiva: revised drug-interaction information.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The FDA added new drug-interaction warnings to the prescribing information for Sustiva (efavirenz).</p>","PeriodicalId":80392,"journal":{"name":"AIDS treatment news","volume":" 421","pages":"5"},"PeriodicalIF":0.0,"publicationDate":"2006-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26643749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Resveratrol: why it matters in HIV.","authors":"John S James","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Large doses of resveratrol (found in small amounts in red wine) made headlines recently for extending the lifespan of mice on an unhealthy diet. This and other substances found in some wines and foods may protect against cardiovascular disease or diabetes, and improve the functioning of mitochondria in cells (which could reduce certain adverse effects of HIV or the drugs used to treat it).</p>","PeriodicalId":80392,"journal":{"name":"AIDS treatment news","volume":" 420","pages":"3-5"},"PeriodicalIF":0.0,"publicationDate":"2006-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26553755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Daily news alerts selected by AIDS Treatment News: www.connotea.org/group/aidsnew.","authors":"John S James","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Now you can follow treatment news as it happens at AIDSNEW, a free service of AIDS Treatment News. We select important, quality reports in medical journals, AIDS treatment sites, and the general press, and publish Web links to them, all in one place at www.connotea.org/group/aidsnew -- often on the first day the news is available anywhere. No need to subscribe, register, or log in. Just visit http://www.connotea.org/group/aidsnew -- then scroll down and click any of the titles for more information. You can use almost any computer and Web browser.</p>","PeriodicalId":80392,"journal":{"name":"AIDS treatment news","volume":" 420","pages":"1-2; appendix 6-8"},"PeriodicalIF":0.0,"publicationDate":"2006-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26553754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Lung cancer: very high death rate with HIV, huge reduction possible with CT screening for early diagnosis.","authors":"John S James","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Lung cancer has a high death rate, especially with HIV in one group of patients studied recently. Researchers are finding that most of the fatalities are due to late diagnosis; as many as 80% of the deaths from lung cancer in the general population might be prevented by CT screening to find the tumors early. The patients with HIV were often relatively healthy, so doctors did not suspect that they had cancer.</p>","PeriodicalId":80392,"journal":{"name":"AIDS treatment news","volume":" 420","pages":"5-6"},"PeriodicalIF":0.0,"publicationDate":"2006-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26553757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Toronto AIDS Conference: calm surface deceptive?","authors":"John S James","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The August 2006 Toronto conference of about 25,000 people had no major controversies--but serious concerns about problems and inadequacies in the response to the global epidemic.</p>","PeriodicalId":80392,"journal":{"name":"AIDS treatment news","volume":" 419","pages":"7-8"},"PeriodicalIF":0.0,"publicationDate":"2006-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26357092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"AIDS information overload: what you can do now.","authors":"John S James","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>New software called Connotea, free and available to everyone, could connect people immediately with the most important work and resources in a wide variety of medical, scientific, service, and activist fields.</p>","PeriodicalId":80392,"journal":{"name":"AIDS treatment news","volume":" 419","pages":"2-5"},"PeriodicalIF":0.0,"publicationDate":"2006-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26357093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Integrase inhibitor MK-0518: Merck opens expanded-access program.","authors":"John S James","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Patients resistant to at least one drug in all three oral classes may qualify for this new kind of antiretroviral--which still must be combined with other active drugs.</p>","PeriodicalId":80392,"journal":{"name":"AIDS treatment news","volume":" 419","pages":"5"},"PeriodicalIF":0.0,"publicationDate":"2006-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26357095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Long-term non-progressors--international study recruiting.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The Elite HIV Controller Study wants a single blood sample from long-term non-progressors anywhere.</p>","PeriodicalId":80392,"journal":{"name":"AIDS treatment news","volume":" 419","pages":"5"},"PeriodicalIF":0.0,"publicationDate":"2006-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26359286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}